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INTRODUCTION 
 Eclampsia is an acute obstetric emergency associated with maternal and 
perinatal morbidity and mortality. Eventhough it is preventable the incidence is 
high in India compared to developed countries. 
 Severe pre-eclampsia with prodromal symptoms is called imminent 
eclampsia.The prodromal symptoms are headache, epigastric pain, nausea, 
vomiting and blurring of vision. Eclampsia is the occurence of seizure or coma 
in pre-eclamptic women. Eclampsia can occur at any period of pregnancy 
antepartum, intrapartum and postpartum. Antepartum eclampsia is more 
common. The classical symptoms of pre-eclampsia is hypertension and 
proteinuria. Some cases may present without this classical symptoms called 
atypical pre-eclampsia/ eclampsia. This study analyse the various determinants 
of eclampsia influencing the maternal and fetal outcome. 
  
MATERIAL AND METHODS 
 
 Prospective study was conducted on patient admitted for imminent 
eclampsia and eclampsia in the department of Obstetrics and Gynaecology, 
Government Theni Medical College during the period of August 2013 to July 
2014.  53 cases of imminent eclampsia and 49 cases of eclampsia were studied 
during this period. 
 History is collected from patient and if patient is unconscious or in postictal 
state, history is collected from attender. A detailed history of the patient 
regarding age, parity, socio-economic status, booking status, gestational age, 
prodromal symptom, details about convulsion, referral and treatment (including 
MgSo4 administration) at referral centre were noted down. Details about 
previous obstetric history were recorded. General examination and obstetric 
examination is done. Loading dose of magnesium sulphate is given as 
therapeutic in all eclampsia and prophylactic in all imminent eclampsia patient. 
Magnesium sulphate is given according to pitchard regimen. Antihypertensives 
Labetalol (oral or iv) and nifidipine given according to blood pressure.  
 Mode of delivery was planned according to gestational age, presentation, 
viability of fetus, cervical scoring and pelvic assessment. Vaginal delivery is 
preferred and induction done with PGE2 gel for patient who was not in labour. 
When patient is in labour, acceleration is done with aminotomy and oxytocin 
infusion. LSCS is done when there is maternal, fetal indication and when PGE2 
induction failed.  
 After delivery the blood pressure was monitored and antihypertensive 
continued. MgSo4 was continued 4
th hourly till 24hours after delivery by 
monitoring patellar reflex, respiratory rate and urine output. 
Details of baby such as birth weight, maturity, sex and complication like 
prematurity, IUGR, birth asphyxia and mortality were recorded. Baby was 
followed till discharge. 
While discharge Patient was advised for contraception and review after 
week. Patient was advised about early booking in next pregnancy. 
  
RESULTS 
 
 Prospective study on 102 antenatal patients conducted from August 2013 to 
July 2014.  
 53 cases of imminent eclampsia and 49 cases of eclampsia were studied. 
 Incidence of imminent eclampsia is 0.97% and that of eclampsia is 0.90%. 
 More number of unbooked cases in eclampsia. 
 Eclampsia is common in young and in primigravida. 
 Eclampsia is common in term gestation. 
 Antepartum eclampsia is more common than intrapartum and postpartum 
eclampsia. 
 90% of imminent eclampsia and eclampsia patient had prodromal 
syndrome. 
 29 out of 53 patient of imminent eclampsia and 22 out of 49 of eclamptic 
patient had diastolic BP >110mmHg. 
 31 out of 53 patient of imminent eclampsia and 28 out of 49 of eclampsia 
patient had systolic BP >160mmHg. 
 39 out of 53 patient of imminent eclampsia and 32 out of 49 of eclampsia 
patient had 3+ or 4+ proteinuria. 
 4 patient of eclampsia and 2 patient of imminent eclampsia had atypical 
presentation. 
 53.06% of patient had 2 – 5 convulsions. 
 42 out of 49 patient of eclampsia were referred our hospital and received 
MgSo4 in first referring unit. Receiving of MgSo4 earlier helps in 
prevention of recurrence of fits and hence reducing maternal complication. 
 Average admission delivery of eclampsia group in our study is 4.50hours. 
Early termination of pregnancy reduce maternal and fetal morbidity and 
mortality. 
  In our study eclampsia patient who delivered within 6hrs had 2.5% of 
perinatal death and no adverse maternal outcome. The onset of convulsion 
to delivery interval was very important to decide maternal and fetal 
outcome 
 In our study, caesarian section is higher. Liberalization of LSCS is done in 
expectation of better maternal and fetal outcome. Liberalization of LSCS 
has been possible due to marked improvements in anesthesiology. 
 49.09% and 38.46% of babies delivered by imminent ecalmpsia and 
eclampsia were preterm babies.  
 70% patient with imminent eclampsia and eclampsia delivered low birth 
weight babies. 
 5.66% of with imminent eclampsia and 4.08% of eclampsia patient had 
HELLP syndrome. 
 Maternal mortality in our study group was 4 patients. 2 patient of 
antepartum eclampsia, 1 patient of postpartum eclampsia and 1 patient of 
imminent eclampsia had died. 
 Perinatal death in imminent eclampsia and eclampsia were 23.6% and 
21.15% respectively. 
  
CONCLUSION  
 
 By analyzing the determinants of eclampsia for better maternal and fetal 
outcome, the crucial factors are duration between the convulsion to first 
treatment and convulsion delivery interval which are achieved by early 
accessibility to receive magnesium sulphate in nearby referring unit and 
decision for early termination of pregnancy at tertiary level hospitals. 
 As compared to the developed countries the incidence of eclampsia is 
high in India. It has a great impact on maternal and fetal morbidity and 
mortality.  Early identification and treatment of this dreadful disease at the 
imminent state itself can reduce the complication. 
 Proper antenatal care, early detection of pre-eclampsia, health education 
about imminent symptom to patient and prompt management of pre-eclampsia 
are essential steps for prevention of eclampsia. 
 In current status on preventive aspect of eclampsia, atypical presentation 
should also be considered for which new screening and diagnostic tools has to 
be developed.  
 
